Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

about

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

Item

http://www.wikidata.org/entity/Q46324177

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

@en

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

@nl

type

Item

label

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

@en

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

@nl

prefLabel

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

@en

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

@nl

P1476

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

@en

P2093

Carrie Snyder

http://www.w3.org/2001/XMLSchema#string

Henry T Lynch

http://www.w3.org/2001/XMLSchema#string

Marc Rendell

http://www.w3.org/2001/XMLSchema#string

Mark Stacey

http://www.w3.org/2001/XMLSchema#string

Megan Hitchins

http://www.w3.org/2001/XMLSchema#string

Murray Joseph Casey

http://www.w3.org/2001/XMLSchema#string

Stephen Lanspa

http://www.w3.org/2001/XMLSchema#string

Theresa Townley

http://www.w3.org/2001/XMLSchema#string

Trudy Shaw

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer

PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies

Opportunities for immunotherapy in microsatellite instable colorectal cancer

Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

P2888

s10689-017-0053-3

P31

scholarly article

P356

10.1007/S10689-017-0053-3

http://www.w3.org/2001/XMLSchema#string

P50

Joan Bailey-Wilson

P577

2017-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29071502

http://www.w3.org/2001/XMLSchema#string